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Abstract
Background: Minimisation ensures excellent balance between groups for several prognostic factors, even in small
samples. However, its use with unequal allocation ratios has been problematic. This paper describes a new
minimisation scheme named sequence balance minimisation for unequal treatment allocations.
Methods: Treatment- and factor-balancing properties were assessed in simulation studies for two- and three-arm
trials with 1:2 and 1:2:3 allocation ratios. Sample sizes were set 30, 60 and 120. The number of prognostic factors on
which to achieve balance was ranged from zero (treatment totals only) to ten with two levels occurring in equal
probabilities. Random elements were set at 0.95, 0.9, 0.85, 0.80, 0.7, 0.6 and 0.5. Characteristics of the randomisation
distributions and the impact of changing the block size while maintaining the allocation ratio were also examined.
Results: Sequence balance minimisation has good treatment- and factor-balancing capabilities, and the randomisation
distribution was centred at zero for all scenarios. The mean and median number of allocations achieved were the same
as the number expected in most scenarios, and including additional factors (up to ten) in the minimisation scheme
had little impact on treatment balance. Treatment balance tended to depart from the target as the random element
was lowered. The variability in allocations achieved increased slightly as the number of factors increased, as the
random element was decreased and as the sample size increased. The mean and median factor imbalance remained
tightly around zero even when the chosen factor was not included in the minimisation scheme, though the variability
was greater. The variability in factor imbalance increased slightly as the random element decreased, as well as when
the number of prognostic factors and sample size increased. Increasing block size while maintaining the allocation
ratio improved treatment balance notably with little impact on factor imbalance.
Conclusions: Sequence balance minimisation has good treatment- and factor-balancing properties and is particularly
useful for small trials seeking to achieve balance across several prognostic factors.
Keywords: Randomisation, Minimisation, Unequal allocation, Randomisation test, Simulation study
Background
This work was motivated by the Hepfree trial (https://
ukctg.nihr.ac.uk/trials/trial-details/trial-details?trialNumber
=ISRCTN54828633), a cluster randomised trial to assess
the impact of screening and treating immigrants from ‘at-
risk’ ethnic minority communities for chronic viral hepa-
titis. This was a relatively small trial with 56 clusters, 5
arms, an unequal allocation ratio and a further aim of
achieving balance on two important prognostic factors.
Minimisation was the preferred allocation method because
it is widely recognised to produce good balance between
groups for several prognostic factors, even in small samples
[1–3]. However, there were concerns regarding what is the
most appropriate minimisation procedure for an unequal
allocation ratio.
Minimisation is based on a different principle from ran-
domisation [1, 2]. It is a valid alternative to randomisation
and has the advantage, especially in trials with a small num-
ber of units, that there will be only minor differences be-
tween groups in those variables used in the allocation
process [1–3]. Such balance is especially desirable where
there are strong prognostic factors and modest treatment ef-
fects, such as oncology [1] and cluster randomised trials [2].
With minimisation, the treatment assigned to the next
participant enrolled in the trial depends (wholly or
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partly) on the characteristics of those participants
already enrolled [1]. The first participant is allocated to
receive a treatment at random, and with each subse-
quent assignment, minimisation works towards finding
the treatment that has the minimum imbalance across
pre-determined prognostic factors [1, 3, 4]. This is done
by calculating an imbalance score for each treatment.
The imbalance score is based on the covariate informa-
tion of the next enrolled participant, all previous alloca-
tions and the hypothetical allocation of the next
participant to each treatment. Treatment allocation that
results in the smallest imbalance score is selected as the
preferred allocation; allocations to the other treatments
are considered non-preferred. At this point, there are
two options. The chosen treatment could simply be
taken as the one with the lower score or a random elem-
ent could be introduced [1]. It is customary to introduce
a random element to make the allocations more unpre-
dictable [5]; the preferred treatment is assigned with a
higher allocation probability, and non-preferred treat-
ments are given low probabilities [5, 6]. In practise, one
has to select that p (i.e., allocation probability) which
strikes a balance between minimising treatment imbal-
ance and avoiding predictability of treatment assign-
ment [5]. Generally, the probabilities are set at some
value higher than 0.5 for the preferred option, and the
remaining probability is equally divided among the
non-preferred. When there are K treatments and k = 1
is the preferred treatment, Pocock and Simon [5] sug-
gested using p1 = p and pk = (1 − p)/(K − 1) for k = 2,…,
K, where p is some constant which must be greater
than 1/K for the treatment assignment to be in favour
of preferred treatment. If p were equal to 1/K, then
each treatment would have an equal probability of be-
ing selected. If p were equal to 1, then the preferred
treatment would be automatically assigned; the chance
of treatment imbalance is minimised, but this may
make the procedure too predictable [5]. For any indi-
vidual trial, there is no obvious decision rule for opti-
mizing one’s choice of p value [5]. This entire process is
repeated for each new unit entering the trial.
Simulation studies show that under similar scenarios,
minimisation provides better-balanced treatment groups
than simple or permuted block randomisation and that
it can incorporate more prognostic factors than stratified
randomisation methods such as permuted blocks within
strata [5, 7]. Although this technique has been evaluated
and applied in studies with equal allocation to two or
more treatment arms, expanding it to unequal allocation
is challenging [8].
Han et al. [6] showed that the minimisation process
needs to be modified for trials involving unbalanced or
unequal treatment allocations. Authors introduced two
modifications. In the first modification, called naive
minimisation, the unequal allocation ratio is accounted
for in calculation of the imbalance score. Once the pre-
ferred treatment is determined, probability assignment
would proceed as for the minimisation process for equal
treatment allocations. Han et al. [6] showed, however,
that this simple modification can lead to deviations from
the target allocation ratio, especially when the allocation
probability given to the preferred treatment is relatively
low. To avoid this problem, they proposed to account
for unequal allocation ratios in determining allocation
probabilities. In their second modification, called biased
coin minimisation (BCM), they varied the allocation
probabilities assigned for each treatment when it is the
preferred treatment, depending on its allocation ratio.
Kuznetsova and Tymofyeyev [8] showed that although
BCM leads to an allocation ratio at the end of the study
that is close to the targeted one, it does not preserve the
allocation ratio at every allocation step. Those authors
argued that if the allocation ratio is not preserved at
every step, the probability of allocation to a particular
treatment tends to fluctuate in periodic cycles, which
provides an opportunity for selection bias throughout
enrolment [8]. Though it is questionable whether in
practise such fluctuations in probability would lead to
selection or evaluation bias in double-blind trials, theor-
etically, when a sequence of covariates of all randomised
patients is known, one can calculate the probability to
assign a particular treatment at the next allocation and
use this knowledge to introduce selection bias in a
double-blind trial [8]. Kuznetsova and Tymofyeyev
showed that such fluctuations are higher when the prob-
ability to allocate to the preferred treatment is higher.
Their method of achieving unequal allocations while
preserving the allocation ratio at every allocation,
worked by executing an equal allocation to S ‘fake’ treat-
ment arms, where S =Q1 +Q2 +… +QK. S is called the
block size, and Q1:Q2: …:QK is the desired allocation ra-
tio to K ≥ 2 treatment groups. In general, as long as the
block size S remained low, this method showed good
balancing properties. However, the authors suggested
using other allocation techniques in smaller studies,
when the allocation ratio leads to a large block size.
Minimisation with unequal allocation ratios and
randomisation test
The randomisation test is based on the idea that if the
given treatment has no effect on the outcome, then the
assignment of that treatment is just a kind of arbitrary
labelling. It is a simulation-based method that usually
begins with choosing a test statistic reflecting the ques-
tion of interest and calculating it for the original data.
Next, the observed test statistic is contrasted with a null
distribution, which is generated by randomly allocating
the data, calculating the test statistic a greater number
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of times [9] and computing a p value as the proportion
of allocations whose test statistic was at least as extreme
as that of the original assignment.
Proschan et al. [10] found serious problems with the
randomisation test for some examples of unequal alloca-
tion minimisation. They pointed out that minimisation
achieves better balance than more conventional random-
isation schemes by restricting the set of likely random-
isation sequences, and when used with unequal
allocation, this can lead to some interesting issues. To
elaborate this problem, they considered a special case
where strict minimisation (i.e., next patient was assigned
to the treatment that minimised imbalance determinis-
tically) was assumed and balance was sought on a single
covariate. They showed that in a two-arm trial (T vs C)
with an allocation ratio of 2:1, within a block of three al-
locations, there are only two treatment assignment pos-
sibilities (i.e., T, C, T with a probability of 2/3 or C, T, T
with a probability of 1/3). The third patient was always
allocated to T. In contrast, block randomisation assigns
all three assignment possibilities—(C, T, T), (T, C, T)
and (T, T, C)—with equal probability. Further, unlike in
permuted block randomisation, when the control obser-
vation (0) and treatment observations (1 and 1) within a
block were fixed, the randomisation distribution
depended on the treatment assignment actually observed
because it depended on the order of the observations;
101 and 011 yield different randomisation distributions.
This led to a striking difference between the randomisa-
tion distributions under strict minimisation and per-
muted block randomisation. Under strict minimisation,
the randomisation distribution does not necessarily have
a mean of 0 (i.e., the mean of the t test statistics was not
centred at 0). It is important to realize that in minimisa-
tion, a randomisation distribution can have a non-zero
mean only with unequal allocation [10].
This paper suggests that the problems with randomisa-
tion tests in unequal allocation minimisation can be
overcome by removing the restrictions imposed on a set
of likely randomisation sequences. For example, in the
case of a two-arm trial (T vs C) with an allocation ratio
of 2:1, this issue could be resolved by achieving all treat-
ment assignment possibilities: (C, T, T), (T, C, T) and (T,
T, C). Furthermore, this paper aims to show that such a
scheme, named sequence balance minimisation, can
achieve the desired treatment and factor balance, espe-
cially in small trials.
Methods
Sequence balance minimisation procedure
There are two essential elements to the minimisation
process: (1) measuring the total imbalance of treatment
numbers and (2) choosing probabilities for assigning
treatments. As with traditional minimisation, sequence
balance minimisation starts with calculating the respect-
ive imbalance scores. At this point, however, unlike in
traditional minimisation, where one treatment is selected
and assigned with a higher probability chosen a priori
(and other treatments are allocated with pre-determined
low probabilities), sequence balance minimisation moves
on to calculate the respective assigning probabilities for
each treatment on the basis of its imbalance score. In es-
sence, sequence balance minimisation combines the two
elements rather than considering them as two distinct
parts of the allocation process. This paper illustrates the
sequence balance minimisation procedure using a nu-
merical example in Table 1. Another important differ-
ence to note is that only those allocations (i.e.,
allocations so far and the number of allocations
remaining) within the current allocation block are con-
sidered in calculating imbalance scores. An allocation
block is defined as the number of allocations equal to
the sum of desired allocation ratios.
For simplicity, the new procedure is described using a
two-arm trial with a 1:2 allocation ratio, seeking to achieve
balance on two factors, gender and ethnic group, each
with two levels. The two treatments are denoted by T1
and T2, and the respective allocation ratios are denoted by
r1 and r2. The allocation block S is defined as the sum of
allocation ratios (i.e., S = r1 + r2). In this scenario, S = 3.
Note that it is possible to have an identical allocation ra-
tion which would sum to a different allocation block size;
for example, an allocation ratio of 2:4 comes out with a
different S value. The effect of varying the allocation block
size in this manner is explored in the next section.
Table 1 shows the numbers with specific baseline char-
acteristics in each treatment group after 30 participants
had entered this trial. Suppose the next enrolled partici-
pant is a white woman. First, the imbalance scores are
calculated for each factor level relevant for the next en-
rolled participant separately. To do this, each factor is
taken in turn, and the imbalance associated with each
treatment is calculated as the difference between ex-
pected and observed numbers of participants allocated
to that treatment divided by the number of allocations
Table 1 Hypothetical distribution of baseline characteristics
after 30 patients are enrolled







Madurasinghe Trials  (2017) 18:207 Page 3 of 20
remaining in the current allocation block. In this example,
with regard to factor 1 (gender), 12 women have already
been allocated in 4 allocation blocks (i.e., 12/3). Therefore,
the next allocation is the first in a new block with all three
allocations remaining (Table 2, column 2). On factor 2 (eth-
nic group), 16 white participants have entered the trial. So
far, five allocation blocks have been completed, and the first
allocation in the sixth allocation block is already made to
T2 (Table 2, column 7), with only two allocations remaining
(i.e., 16/3). Therefore, T1 imbalance for factors 1 and 2 are
|1-0|/3 (Table 2, columns 4 and 5) and |1-0|/2, respectively
(Table 2, columns 9 and 10). For T2, the imbalance is |2-0|/
3 (Table 2, columns 4 and 5) and |2-1|/2 (Table 2, columns
9 and 10) on factors 1 and 2, respectively. This measure is
defined as a non-negative value, and the imbalance
score for treatments with a greater-than-expected num-
ber of allocations are set to zero. Then these individual
scores are divided by the sum of all individual treat-
ment imbalances for that factor to derive the adjusted
imbalance scores. In this example, adjusted factor 1 im-
balance scores are 1/3 and 2/3 (Table 2, column 5), and
adjusted factor 2 imbalance scores are 1/2 and 1/2
(Table 2, column 10), respectively. If there is only one
prognostic factor on which to achieve balance, these
adjusted imbalance scores (denoted by ai) provide the
respective assignment probabilities for each treatment.
When there is more than one prognostic factor (as in
this example), the adjusted factor imbalance score for each
treatment is combined across all n prognostic factors to
derive the appropriate treatment assignment probabilities.
In combining, the individual factor imbalance scores are
weighted so that factors with lesser numbers of allocations
remaining in their current block are given the priority by
giving a greater weight. The idea is that when there are
fewer allocations remaining, there are fewer opportunities
to correct for any imbalances that may occur by chance.





ai = treatment allocation ratio; for 0 > ai > 1
sum of allocation ratios = treatment allocation ratio;




The total imbalance for each treatment is calculated
by summing the weighted imbalance scores across all
prognostic factors. Here, if some prognostic factors are
considered more important than others, those could be
given a greater weight. Allocation probabilities are calcu-
lated by dividing of the each treatment total imbalance
scores by overall treatment imbalance score across all
treatments. The assignment probabilities for T1 and T2
are 0.42 and 0.58, respectively (Table 2). A random
element can be used to minimise the predictability when
calculated assignment probability is 1.
Simulation study
The treatment- and factor-balancing properties of se-
quence balance minimisation were explored for trials
with 1:2 and 1:2:3 allocation ratios, seeking to achieve
balance on one to ten prognostic factors, with each fac-
tor assumed to have two levels occurring in equal prob-
ability. The impact of incorporating treatment totals as
an additional prognostic factor in the minimisation
scheme was assessed under three weighting schemes: (1)
weight of 0 (i.e., treatment totals are not included), (2)
weight of 1 (i.e., treatment totals are given the same
weight as other prognostic factors) and (3) weighted as
the total number of prognostic factors on which to
achieve balance (i.e., treatment balance is considered
more important by giving it a greater weight). Sample
sizes were set at 30, 60 and 120. A random element was
used when the assigning probability was calculated as 1.
These were set at 0.95, 0.9, 0.85, 0.80, 0.7, 0.6 and 0.5 for
the treatment with lowest allocation ratio, and the Han
et al. [6] formula was used to calculate the allocation
probabilities for non-preferred treatments. For each sce-
nario, 1000 trials were simulated. For each trial, overall
treatment and factor imbalance were calculated as the
difference between expected and achieved allocations.
Characteristics of the randomisation distribution were
explored for a continuous outcome (Fig. 1).
As a proof of concept, treatment balance was simu-
lated for the best-case scenario, where treatments were
assigned with probability of 1 when the assigning prob-
ability was calculated as 1 and only treatment totals were
considered in the minimisation scheme, which is the
worst-case scenario for factor imbalance when a chosen
factor is ignored in the minimisation scheme.
Table 2 Illustrative example of sequence balance minimisation
Next
allocation



















T1 0 1 1 − 0 1/3 0.4 0 1 1 − 0 1/2 0.6 0.42
T2 0 2 2 − 0 2/3 0.57 1 2 2 − 1 1/2 0.43 0.58
aIf minimising on one factor, imbalance scores provide the respective assigning probabilities
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Results
Balancing properties and randomisation distribution of
sequence balance minimisation
The mean and median numbers of treatment allocations
achieved under the best-case scenario were the same as
the number expected with the following mean (SE)
values: 10 (0), 20 (0) and 40 (0), and median (p1–p99):
10 (10–10), 20 (20–20), and 40 (40–40), for sample sizes
30, 60 and 120, respectively. The factor imbalance:
values (mean ([se]): were as follows: 5 (0.04), 10 (0.05)
and 20 (0.09), and median (p1– p99): 5 (2–8), 10 (6.5–
13.5) and 20 (14–26.5), for sample sizes 30, 60 and 120,
respectively.
The overall treatment imbalance in the treatment arm
with lower allocation ratio is summarised in Tables 3, 4
and 5. The results show that sequence balance mini-
misation provide good treatment balance. The overall
treatment balance however tends to depart from the tar-
get as the random element assumed for the preferred
treatment was decreased. This was particularly so, when
there was only one minimisation factor. Including add-
itional prognostic factors (up to 10) in the minimisation
scheme had little impact on overall treatment balance;
the mean and median number of allocations achieved
was as same as the expected number. However the
variability in allocations achieved increased slightly as
the number of prognostic factors increased, and also
when the probabilities assumed for random element
lowered. This was also the case when the sample size
increased. The variability in allocations achieved was
reduced as the weight given to treatment totals in-
creased (Table 5).
Tables 6, 7 and 8 present the factor imbalance with
respect to factor 1 in all scenarios. The treatment
totals-only column represents the worst-case imbal-
ance for the chosen factor 1, in which it was ignored
in the minimisation scheme. The variability in factor
imbalance followed patterns similar to those of treat-
ment imbalance; increasing slightly as the probability
assumed for random elements lowered and also as the
number of prognostic factors and sample size in-
creased. The mean and median factor imbalance
remained tightly around zero even when factor 1 was
not included in the minimisation scheme, though the
variability in allocation distribution was greater. Fur-
ther, it was interesting to note that the factor imbal-
ance did not increase as the weight given to treatment
totals in the allocation scheme increased (Table 8).
Fig. 1 Randomisation distribution with 1:2 allocation ratio and sample sizes 30, 60 and 120
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Figure 1 shows the randomisation distributions for
all scenarios considered in simulations. The mean
treatment difference in randomisation distribution
was zero, with original overall treatment differences
laid outside the 2.5th to 97.5th percentile range. The
variability in treatment differences decreased (i.e.,
2.5th to 97.5th percentile range narrowing) as the
sample size increased. This was particularly notable
when the treatment totals were weighted zero in the
allocation scheme.
Balancing properties and characteristics of the ran-
domisation distribution for a three-arm trial with 1:2:3
allocation ratio under all scenarios considered before
(results presented in Additional file 1) were also exam-
ined. The treatment- and factor-balancing properties
were quite good. It is clear that as the number of prog-
nostic factors increased, the treatment balance tended to
deteriorate gradually. In randomisation distributions,
similar to 1:2 allocation, the mean treatment difference
was zero for all scenarios.
The effect of increasing allocation block size from 3
with 1:2 allocation ratio to 6 with 2:4 ratio, to 15 with
5:10 ratio, and to 30 with 10:20 ratio while maintaining
the treatment allocation ratio is presented in Fig. 2. Sam-
ple sizes were set at 30 and 120. It is clear that as the
block size increased, the variability in treatment balance
reduced notably. This improved treatment balance ap-
peared to come with little impact on variability in factor
balance. The overall mean and median treatment and
factor imbalance remained close to zero for all scenarios.
Discussion
Minimisation is a dynamic randomisation technique that
has been used widely in clinical trials for achieving a bal-
ance of prognostic factors across treatment groups [6].
The validity of minimisation has been supported by
simulation studies in the case of balanced treatment al-
location [5]. However, there are problems with using
minimisation in unequal allocation ratios, including de-
viation from the target allocation ratio, particularly when
the preferred treatment is assigned a probability value
that is relatively low [6] and the randomisation distribu-
tion does not necessarily have a mean value of 0 [10].
The latter is not necessarily an issue peculiar to mini-
misation [11]. It is common to all unequal allocation
procedures for which the allocation ratio varies from al-
location to allocation [11]. This paper proposes a new
minimisation procedure for unequal treatment alloca-
tion. The results show that it can achieve the necessary
unequal allocation ratio set in trial design, and it per-
formed well in randomisation tests. Further, adding
additional prognostic factors in this scheme had little
impact on overall treatment and factor balance.
Generally, conventional minimisation algorithms con-
sider only all allocations performed thus far when
determining the preferred treatment and assigned with
a pre-determined probability. It is customary to use a
random probability to make the allocations more un-
predictable. The method described here differs with re-
gard to two main aspects of this usual case. Firstly, it
includes both previous and remaining allocations
within the current allocation block in determining
assigning probabilities. Secondly, treatment assignment
probabilities are not chosen a priori, but calculated for
each allocation separately, which serves to reduce the
predictability of allocations. A random element is used
only when the calculated treatment assignment prob-
ability is 1.
Proschan et al. [10] uncovered serious problems with
the randomisation test in unequal allocation minimisa-
tion. They showed that minimisation achieves better bal-
ance than more conventional randomisation schemes by
restricting the set of likely randomisation sequences.
Sequence balance minimisation seeks to remove this re-
striction and allow all possible combinations of treat-
ment assignment, thus producing randomisation
distributions with a mean value of zero. This paper pro-
vides research evidence to prove the concept; that when
treatments are assigned deterministically where required
(best-case scenario), sequence balance minimisation
achieves the expected number of allocations with the
mean of the randomisation distribution centred at 0.
The results further show that sequence balance mini-
misation performs well even when a random element is
introduced, as is customary in minimisation.
In covariate adaptive randomisation schemes such as
minimisation, when the full sequence of covariates is
known, there is a remote possibility that investigators
may able to guess what the next treatment will be and
introduce selection bias [5, 8]. In sequence balance mini-
misation, however, full knowledge of covariate sequences
is not sufficient; the current treatment allocation se-
quence and block size would also need to be known. In
double-blind trials, investigators are blinded to treat-
ment allocations. To completely eliminate the possibility
for selection or evaluation bias, Kuznetsova et al. [8]
suggested masking the order of patients’ entry into the
trial. In sequence balance minimisation, it is also pos-
sible to change the block size.
The accidental bias arising from any non-random
order of patients entering the trial (e.g., any time trends
in the prognostic mix of patients entering the trial)
could bias treatment differences [5, 8, 12]. Block ran-
domisation and block-stratified analysis have been sug-
gested to eliminate such confounding of the results by
time trends [12]. Randomising in blocks is a built-in fea-
ture of sequence balance minimisation which would
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reduce the possibility of accidental bias. The extent to
which this would eliminate accidental bias could be
addressed in future research. Furthermore, this method
performed well under equal allocation ratios (results not
presented) as well as unequal allocations, and it is also
easy to implement, even when the allocation ratio leads
to a large block size. However, the present findings indi-
cate that further research is needed to address the ques-
tion of what is the most appropriate, block size or
random element combination, for a particular allocation
ratio and sample size, as well as the impact of varying
block size and methods for calculating the random elem-
ent, which would serve to reduce the predictability.
Conclusions
Minimisation is an allocation scheme particularly useful
for trials with small samples because of its ability to en-
sure balance between the groups on several prognostic
factors. The problems with randomisation tests have cast
doubts on using minimisation for unequal allocations
Fig. 2 Treatment and factor balance with varying allocation block sizes: 3, 6, 15 and 30, treatment allocation ratio 1:2, sample sizes 30 and 120
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[10]. This paper describes a new minimisation procedur-
e—sequence balance minimisation—for assigning treat-
ments in unequal allocation ratios. It demonstrated good
treatment- and factor-balancing properties, and also its
randomisation distribution has a mean value of zero, re-
storing the usefulness of minimisation, particularly in
small trials seeking to achieve balance across several
prognostic factors.
Additional file
Additional file 1: Table S1. Treatment-balancing properties of 1:2:3
sequence balance minimisation with one to ten factors with two levels,
treatment totals weighted as zero, random element = 0.95 to 0.5. Table
S2. Treatment-balancing properties of 1:2:3 sequence balance minimisa-
tion with zero (treatment totals only) to ten factors with two levels, treat-
ment totals weighted as one, random element = 0.95 to 0.5. Table S3.
Treatment-balancing properties of 1:2:3 sequence balance minimisation
with zero (treatment totals only) to ten factors with two levels, treatment
totals weighted as total number of minimisation factors, random element
= 0.95 to 0.5. Table S4. Factor-balancing properties of 1:2:3 sequence bal-
ance minimisation with one to ten factors with two levels, treatment to-
tals weighted as zero, random element = 0.95 to 0.5. Table S5. Factor-
balancing properties of 1:2:3 sequence balance minimisation with one to
ten factors with two levels, treatment totals weighted as one, random
element = 0.95 to 0.5. Table S6. Factor-balancing properties of 1:2:3 se-
quence balance minimisation with one to ten factors with two levels,
treatment totals weighted as total number of minimisation factors, ran-
dom element = 0.95 to 0.5. Figure S1. Randomisation distributions with
1:2:3 allocation ratio, mean differences for two treatments with smaller-
allocation ratio (n = 5 vs 10, 10 vs 20, and 20 vs 40). (DOC 1426 kb)
Abbreviations
BCM: Biased coin minimisation
Acknowledgements
The author thanks Professor Sandra Eldridge and Professor Richard Hooper
for their invaluable comments on earlier versions of the manuscript.
Funding
No funding was available for this study.
Availability of data and materials
Summarised supporting data are provided in this manuscript.
Author’s contributions
VWM developed the concept for sequence balance minimisation, designed
and conducted the simulations, and drafted this manuscript.
Competing interests
The author declares that he/she has no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 2 December 2016 Accepted: 11 April 2017
References
1. Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;
330(7495):843.
2. Ivers NM, Halperin IJ, Barnsley J, Grimshaw JM, Shah BR, Tu K, et al.
Allocation techniques for balance at baseline in cluster randomized trials: a
methodological review. Trials. 2012;13:120.
3. Roberts C, Torgerson D. Randomisation methods in controlled trials. BMJ.
1998;317(7168):1301–10.
4. Sedgwick P. Treatment allocation by minimisation. BMJ. 2013;347:f6569.
5. Pocock SJ, Simon R. Sequential treatment assignment with balancing for
prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103–15.
6. Han B, Enas NH, McEntegart D. Randomization by minimization for
unbalanced treatment allocation. Stat Med. 2009;28(27):3329–46.
7. Therneau TM. How many stratification factors are “too many” to use in a
randomization plan? Control Clin Trials. 1993;14(2):98–108.
8. Kuznetsova OM, Tymofyeyev Y. Preserving the allocation ratio at every
allocation with biased coin randomization and minimization in studies with
unequal allocation. Stat Med. 2012;31(8):701–23.
9. Holmes AP. Statistical issues in functional brain mapping. Dissertation,
University of Glasgow; 1994
10. Proschan M, Brittain E, Kammerman L. Minimize the use of minimization
with unequal allocation. Biometrics. 2011;67(3):1135–41.
11. Kuznetsova OM. Considerations in the paper by Proschan, Brittain, and
Kammerman are not an argument against minimization. In response to
Vance W Berger ‘Minimization: not all it’s cracked up to be’, Clin Trials 2011;
8: 443. Clin Trials. 2012;9(3):370.
12. Korn EL, Freidlin B. Outcome-adaptive randomization: is it useful? J Clin
Oncol. 2011;29(6):771–6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Madurasinghe Trials  (2017) 18:207 Page 20 of 20
